Aug 19, 2021 / 07:00AM GMT
Operator
Good day, everyone, and thank you for attending Hua Medicine's 2021 Interim Results Conference Call hosted by ICA Investor Relations, the company's Investor Relations adviser. Today's call is being recorded.
On the call today are Dr. Li Chen, Founder, Chief Executive Officer, Chief Scientific Officer and Executive Director; and Mr. George Lin, Chief Financial Officer and Executive Director. Dr. Li Chen will start the call with an overview of the company's highlights, including clinical trials and recognitions, followed by a pipeline update. And then, Mr. George Lin will give his thoughts on the numbers and the updated guidance before we open up the call for Q&A. Management will be available to answer your questions during the Q&A session that follows.
During the presentation, you will be able to submit your questions in written format in Zoom's chat box or Q&A channel. Alternatively, you could virtually raise your hand on Zoom for an opportunity to speak with the management team during the Q&A session.
For your information, this call may contain forward-looking
Half Year 2021 Hua Medicine Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot